Consuelo Treviño-Garza

Prof. Dr. Consuelo Treviño-Garza


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2013 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJoanne Langley
Joanne Langley
AMAlfonso Carmona Martinez
Alfonso Carmona Martinez
ACArchana Chatterjee
Archana Chatterjee
SHScott A. Halperin
Scott A. Halperin
SMShelly McNeil
Shelly McNeil
VJVarsha K. Jain
Varsha K. Jain
Background. Mismatch between circulating influenza B viruses (Yamagata and Victoria lineages) and vaccine strains occurs frequently. Methods. In a randomized controlled trial, immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate (QIV) versus trivalent inactivated influenza vaccine (TIV)-Victoria(Vic) and TIV-Yamagata(Yam) in children 3–17 years of age was evaluated. In an open-label study arm, QIV only was assessed in children 6–35 months of age. Results. A total of 3094 children (932 QIV, 929 TIV-Vic, 932 TIV-Yam, and 301 QIV only) were vaccinated. QIV was noninferior to the TIVs for shared strains (A/H3N2 and A/H1N1) based on hemagglutination-inhibition (HI) antibodies 28 days after last vaccination, and superior for the unique B strains Victoria and Yamagata (geometric mean titer ratios 2.61, 3.78; seroconversion rate differences 33.96%, 44.63%). Among children in the randomized trial, adverse event rates were similar except for injection site pain (dose 1: 65.4% QIV, 54.6% TIV-Vic, 55.7% TIV-Yam). Conclusion. QIV elicited superior HI responses to the added B strains compared to TIV controls, potentially improving its effectiveness against influenza B. HI responses were similar between QIV and TIV controls for the shared strains. QIV had an acceptable safety profile relative to TIVs. Clinical Trials Registration. NCT01198756.

24 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DADaniel Arellanos-Soto
Daniel Arellanos-Soto
Gerardo Padilla-RivasGerardo Padilla-Rivas
Gerardo Padilla-Rivas
JRJavier Ramos-Jimenez
Javier Ramos-Jimenez
KGKame Galan-Huerta
Kame Galan-Huerta
SLSonia Lozano-Sepulveda
Sonia Lozano-Sepulveda
ARAna M. Rivas-Estilla
Ana M. Rivas-Estilla
Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. In this study we compared influenza activity indicators in our country after the implementation of public health measures for COVID-19. We compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases/deaths. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, influenza positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019. Our results suggest that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases as influenza in our country.

25 March 2016 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
CTConsuelo Treviño-Garza
Consuelo Treviño-Garza
LVLaura Villarreal-Martínez
Laura Villarreal-Martínez
CECynthia M. Estrada-Zúñiga
Cynthia M. Estrada-Zúñiga
MLMariana Leal-Treviño
Mariana Leal-Treviño
IRIsaías Rodríguez-Balderrama
Isaías Rodríguez-Balderrama
MOManuel de la O-Cavazos
Manuel de la O-Cavazos
In the development of the foetal immune system, cytokines play an important role in its function. Therefore, we sought to determine whether the mode of delivery affects the expression of leptin, IL-6 and TNF-α in umbilical cord blood in healthy term newborns. We collected 125 samples of umbilical cord blood to analyse leptin, IL-6 y TNF-α levels with multiplex immunoassay (MIA). The samples were classified according to mode of delivery: vaginal delivery (VD) and caesarean section (CS). Leptin and IL-6 had higher concentrations in umbilical cord blood in VD than in CS: 42.55 ng/ml (11.92–104.28) versus 35.20 ng/ml (3.26–9326.76), p = 0.039; 9.32 pg/ml (1.13–2020.31) versus 3.81 pg/ml (0.52–834.69) p < 0.001, respectively. Also, a weak correlation between TNF-α and IL-6 was found (r = 0.238, p = 0.007). The most important finding in our study was the differential concentrations of leptin and IL-6 according to mode of delivery.

1 July 2010 in Archives of Medical Research
Verified
Journal Article
Closed access
CTConsuelo Treviño-Garza
Consuelo Treviño-Garza
FBFrancisco J. Bosques-Padilla
Francisco J. Bosques-Padilla
CECynthia M. Estrada-Zúñiga
Cynthia M. Estrada-Zúñiga
LMLeonardo Mancillas-Adame
Leonardo Mancillas-Adame
JPJesús Zacarías Villarreal Pérez
Jesús Zacarías Villarreal Pérez
JAJesús Argente
Jesús Argente

1 September 2020 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
FMFernando Montes-Tapia
Fernando Montes-Tapia
KHKarla Hernández-Trejo
Karla Hernández-Trejo
FGFernando García-Rodríguez
Fernando García-Rodríguez
JJJulio Jaime-Reyes
Julio Jaime-Reyes
CTConsuelo Treviño-Garza
Consuelo Treviño-Garza
MOManuel de la O-Cavazos
Manuel de la O-Cavazos

24 June 2021 in Viruses
Verified
Journal Article
Open access
PDF file
NMNatalia Martinez-Acuña
Natalia Martinez-Acuña
Diana Nolazco-AvalosDiana Nolazco-Avalos
Diana Nolazco-Avalos
DRDiana Raquel Rodríguez-Rodríguez
Diana Raquel Rodríguez-Rodríguez
CMCynthia Gabriela Martinez-Liu
Cynthia Gabriela Martinez-Liu
KGKame Galan-Huerta
Kame Galan-Huerta
ARAna M. Rivas-Estilla
Ana M. Rivas-Estilla
The progression and distribution of the SARS-CoV-2 pandemic are continuously changing over time and can be traced by blood donors’ serological survey. Here, we investigated the seroprevalence of anti-SARS-CoV-2 antibodies in blood donors in Nuevo Leon, Mexico during 2020 as a strategy for the rapid evaluation of the spread of SARS-CoV-2 and asymptomatic case detection. We collected residual plasma samples from blood donors who attended two regional donation centers from January to December of 2020 to identify changes in anti-SARS-CoV-2 IgG prevalence. Plasma samples were analyzed on the Abbott Architect instrument using the commercial Abbott SARS-CoV-2 IgG chemiluminescent assay. We found a total of 99 reactive samples from 2068 analyzed plasma samples, resulting in a raw prevalence of 4.87%. Donors aged 18–49 years were more likely to be seropositive compared to those aged >50 years (p < 0.001). Weekly seroprevalence increased from 1.8% during the early pandemic stage to 27.59% by the end of the year. Prevalence was 1.46-fold higher in females compared to males. Case geographical mapping showed that Monterrey city recorded the majority of SARS-CoV-2 cases. These results show that there is a growing trend of seroprevalence over time associated with asymptomatic infection that is unnoticed under the current epidemiological surveillance protocols.